Results 11 to 20 of about 10,145 (225)

Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula. [PDF]

Pediatr Pulmonol
ABSTRACT Background Heated, humidified, high‐flow nasal cannula (HFNC) before intubation has been associated with increased mortality in children with immunocompromising conditions (ICC). Objectives We sought to describe HFNC failure (intubation) rate and aimed to develop a novel score associated with HFNC failure.
Mai MA, Rogerson CM, Rowan CM.
europepmc   +2 more sources

Use of High-Flow Nasal Cannula in Amyotrophic Lateral Sclerosis Patients Intolerant to Non-Invasive Ventilation: A Case Series. [PDF]

Respirol Case Rep
In this case series of 18 patients with amyotrophic lateral sclerosis and intolerance to non‐invasive ventilation, high‐flow nasal cannula was feasible as home‐based respiratory support. Gas exchange remained stable during follow‐up despite progressive functional decline, supporting further evaluation of HFNC as an alternative or complementary strategy
Varon-Vega F, Franco Parra CE, Adame Ochoa DF, Uricoechea N, Tuta-Quintero E, Martinez Ayala MC.   +5 more
europepmc   +2 more sources

Characteristics of patients treated with HFNC: Comparison of HFNC success with HFNC failure requiring intubation.

, 2022
Characteristics of patients treated with HFNC: Comparison of HFNC success with HFNC failure requiring intubation.
Marion Faucher (4281526), Jérôme Lambert (4094932), Magali Bisbal (4281508), Antoine Sannini (4281514), Djamel Mokart (3533894), Colombe Saillard (8957819), Morgane Tramier (12975453), Luca Servan (6678395), Jean-Manuel de Guibert (12975456), Frederic Gonzalez (10687946), Laurent Chow-Chine (4281517)   +10 more
core   +1 more source

HFNC

, 2023
HFNC in long-term ...
Tyler Pitre
core   +1 more source

Treatment outcome of HFNC-treatment.

, 2022
Treatment outcome of HFNC-treatment.
Pieter Veenstra (13911597), Nic J. G. M. Veeger (9110620), Ralph J. H. Koppers (13911600), Wouter H. van Geffen (13242731), Marieke L. Duiverman (13911603)   +4 more
core   +1 more source

Characteristics of patients experiencing HFNC therapy failure.

, 2022
Characteristics of patients experiencing HFNC therapy failure.
Marion Faucher (4281526), Jérôme Lambert (4094932), Magali Bisbal (4281508), Antoine Sannini (4281514), Djamel Mokart (3533894), Colombe Saillard (8957819), Morgane Tramier (12975453), Luca Servan (6678395), Jean-Manuel de Guibert (12975456), Frederic Gonzalez (10687946), Laurent Chow-Chine (4281517)   +10 more
core   +1 more source

Comparison of ROX index (SpO2/FIO2 ratio/respiratory rate) with a modified dynamic index incorporating PaO2/FIO2 ratio and heart rate to predict high flow nasal cannula outcomes among patients with acute respiratory failure: a single centre retrospective study

BMC Pulmonary Medicine, 2022
Background High flow nasal cannula (HFNC) is increasingly being used to support patients with acute respiratory failure (ARF) and to avoid need for intubation. However, almost one third of the patients do not respond and require escalation of respiratory
Amit Kansal, Wei Jun Dan Ong, Shekhar Dhanvijay, Arbe Tisha Pepito Siosana, Loraine Mae Padillo, Chee Keat Tan, Monika Gulati Kansal, Faheem Ahmed Khan   +7 more
doaj   +1 more source

Daily ROX index values between patients in the HFNC failure group and those in the HFNC success group.

, 2023
HFNC, high-flow nasal cannula; ROX, respiratory rate-oxygenation.
Todspol Lertwattanachai (16412797), Konlawij Trongtrakul (12629744), Pruchwilai Nuchpramool (16412791), Piyarat Phairatwet (16412794), Sujaree Poopipatpab (8930363)   +4 more
core   +1 more source

Treatable traits for HFNC in included COPD-patients.

, 2022
Treatable traits for HFNC in included COPD-patients.
Pieter Veenstra (13911597), Nic J. G. M. Veeger (9110620), Ralph J. H. Koppers (13911600), Wouter H. van Geffen (13242731), Marieke L. Duiverman (13911603)   +4 more
core   +1 more source

Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis [PDF]

, 2021
Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients.
Sun, Xiaocong, Deng, L, Lei, S, Applegate, RL, Xia, Zhongyuan, Wang, Zheng, Xia, Zhengyuan, Lei, Shaoqing, Lubarsky, David A, Zhang, Yuanli, Zhang, Liangqing, Zhou, Dunrong, Lubarsky, DA, Han, C, Cheung, CW, Wang, S, Mai, Zhenhua, Jiang, F, Tang, J, Wang, X, Wang, Z, Jiang, Fang, Zhou, D, Applegate, Richard L, Xia, Z, Liu, Danyong, Liu, Hong, Zhang, Y, Wang, Sheng, Liu, H, Cheung, Chi Wai, Liu, D, Tang, Jing, Han, Conghua, Zhang, L, Wang, Xiaoyan, Sun, X, Mai, Z, Deng, Liehua, Xiaocong Sun, Fang Jiang, Sheng Wang, Richard L Applegate, Liehua Deng, Zhenhua Mai, Liangqing Zhang, Conghua Han, Zhengyuan Xia, Zhongyuan Xia, Xiaoyan Wang, Danyong Liu, Shaoqing Lei, Dunrong Zhou, Hong Liu, Zheng Wang, Yuanli Zhang, Jing Tang, David A. Lubarsky, Chi Wai Cheung   +58 more
core   +1 more source